Menu Back toLS12: How should We Collaborate Together to Enhance Model-Informed Drug Development?

18th DIA Japan Annual Meeting 2021

All prices are exclusive of 10% Japanese consumption tax

LS12: How should We Collaborate Together to Enhance Model-Informed Drug Development?

Session Chair(s)

Atsushi  Tsukamoto, PhD, MSc

Atsushi Tsukamoto, PhD, MSc

  • Vice President, Development Regulaotry Affairs
  • Daiichi Sankyo Company, Limited, Japan

Speaker(s)

Takayo  Ueno

Takayo Ueno

  • Director, Clinical Pharmacology Strategy
  • Bristol Myers Squibb, Japan
Norisuke  Kawai, PhD

Norisuke Kawai, PhD

  • Senior Director, Biometrics & Data Management
  • Pfizer R&D Japan G.K., Japan
Daisuke  Iwata

Daisuke Iwata

  • Office of Advanced Evaluation with Electronic Data
  • Pharmaceuticals and Medical Devices Agency, Japan

Contact us